Top compounds associated with response to PEPD


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CCLE pan-cancer AAC -0.16 0.0002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0002
mRNA PI-103 GDSC1000 pan-cancer AAC -0.11 0.0004
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.11 0.0004
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.11 0.0005
mRNA YM-155 GDSC1000 pan-cancer AAC -0.12 0.0006
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.11 0.0007
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.1 0.0007
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.11 0.0007
Download CSV